106190 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
HIGH TECH PHARM Co., Ltd. engages in the manufacture and sale of raw materials for injectable antibiotic products. Its products include carbapenem, imipenem, cilastatin sodium, blended imipenem-cilastatin sterile, meropenem, panipenem, and faropenem. The company was founded in April 1998 and is headquartered in Chungju-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
106190 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company